ZENTALIS PHARMACEUTICALS ANNOUNCES MEANINGFUL MEDIAN OVERALL SURVIVAL DATA IN CYCLIN E1-POSITIVE PLATINUM-RESISTANT OVARIAN CANCER FROM DENALI PART 1B TO BE PRESENTED AT THE ESMO CONGRESS 2026

Reuters · 2d ago

Please log in to view news